Mild-to-moderate disease | Severe disease | |||
---|---|---|---|---|
Age group | n (%*) | Median months (IQR) | n (%*) | Median months (IQR) |
Time from first musculoskeletal symptom to SLE diagnosis | ||||
0–9 years | 1 (0.07) | – | 0 | – |
10–19 years | 20 (1.4) | 6.0 (2.8–27.7) | 18 (1.3) | 29.7 (2.3–21.3) |
20–19 years | 57 (4.0) | 13.9 (5.1–26.5) | 15 (1.1) | 3.8 (1.2–20.6) |
30–39 years | 122 (8.6) | 22.2 (7.9–39.9) | 42 (2.9) | 14.5 (5.7–37.8) |
40–49 years | 154 (10.8) | 28.7 (14.6–46.0) | 29 (2.0) | 7.9 (3.8–29.2) |
50–59 years | 133 (9.3) | 29.1 (17.5–16.2) | 45 (3.2) | 25.6 (10.6–37.3) |
60–69 years | 83 (5.8) | 36.1 (15.8–49.6) | 41 (2.9) | 34.4 (14.4–45.4) |
70–79 years | 68 (4.8) | 30.6 (16.9–49.4) | 31 (2.2) | 38.9 (12.7–48.0) |
80+ years | 21 (1.5) | 33.9 (18.6–50.4) | 4 (0.3) | 44.3 (28.3–49.5) |
Time from first mucocutaneous symptom to SLE diagnosis | ||||
0–9 years | 4 (0.3) | 7.8 (3.9–12.7) | 1 (0.07) | – |
10–19 years | 15 (1.1) | 6.5 (1.7–26.1) | 15 (1.1) | 23.2 (2.9–45.4) |
20–19 years | 34 (2.4) | 17.0 (9.5–45.1) | 9 (0.6) | 26.8 (3.5–43.1) |
30–39 years | 74 (5.2) | 25.5 (10.2–41.2) | 24 (1.7) | 18.9 (6.4–28.2) |
40–49 years | 116 (8.1) | 21.4 (9.9–41.7) | 20 (1.4%) | 14.3 (2.3–21.8) |
50–59 years | 65 (4.6) | 13.5 (5.2–32.4) | 22 (1.5) | 20.9 (5.5–38.7) |
60–69 years | 77 (5.4) | 17.5 (8.7–36.7) | 20 (1.4) | 23.7 (3.8–37.4) |
70–79 years | 53 (3.7) | 23.0 (8.1–34.1) | 16 (1.1) | 9.7 (3.2–30.1) |
80+ years | 17 (1.2) | 16.1 (7.2–28.6) | 3 (0.2) | 4.7 (2.8–41.6) |
*Percentages calculated for all SLE cases (n=1426).
CPRD, Clinical Practice Research Database.